176 related articles for article (PubMed ID: 23061567)
21. Synthesis, bioconversion, pharmacokinetic and pharmacodynamic evaluation of N-isopropyl-oxy-carbonyloxymethyl prodrugs of CZh-226, a potent and selective PAK4 inhibitor.
Guo J; Wang T; Wu T; Zhang K; Yin W; Zhu M; Pang Y; Hao C; He Z; Cheng M; Liu Y; Zheng J; Gu J; Zhao D
Eur J Med Chem; 2020 Jan; 186():111878. PubMed ID: 31757524
[TBL] [Abstract][Full Text] [Related]
22. Bisphosphonate prodrugs: synthesis and biological evaluation in HuH7 hepatocarcinoma cells.
Monteil M; Migianu-Griffoni E; Sainte-Catherine O; Di Benedetto M; Lecouvey M
Eur J Med Chem; 2014 Apr; 77():56-64. PubMed ID: 24607589
[TBL] [Abstract][Full Text] [Related]
23. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
Wang Y; Xin D; Liu K; Zhu M; Xiang J
Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
[TBL] [Abstract][Full Text] [Related]
24. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.
Xiao H; Yan L; Zhang Y; Qi R; Li W; Wang R; Liu S; Huang Y; Li Y; Jing X
Chem Commun (Camb); 2012 Nov; 48(87):10730-2. PubMed ID: 23012698
[TBL] [Abstract][Full Text] [Related]
25. Two-step activation prodrugs: transplatin mediated binding of chemotherapeutic agents to vitamin B12.
Tran MT; Furger E; Alberto R
Org Biomol Chem; 2013 May; 11(19):3247-54. PubMed ID: 23584074
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of anticancer activity of BOC26P, an ortho-aryl chalcone sodium phosphate as water-soluble prodrugs in vitro and in vivo.
Zhu C; Wang R; Zheng W; Chen D; Yue X; Cao Y; Qin W; Sun H; Wang Y; Liu Z; Li B; Du J; Bu X; Zhou B
Biomed Pharmacother; 2017 Dec; 96():551-562. PubMed ID: 29032339
[TBL] [Abstract][Full Text] [Related]
27. In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.
Radi M; Adema AD; Daft JR; Cho JH; Hoebe EK; Alexander LE; Peters GJ; Chu CK
J Med Chem; 2007 May; 50(9):2249-53. PubMed ID: 17419604
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of quercetin-3-O-acyl esters as topical prodrugs.
Montenegro L; Carbone C; Maniscalco C; Lambusta D; Nicolosi G; Ventura CA; Puglisi G
Int J Pharm; 2007 May; 336(2):257-62. PubMed ID: 17257788
[TBL] [Abstract][Full Text] [Related]
29. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR
Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526
[TBL] [Abstract][Full Text] [Related]
30. A cancer specific oxaliplatin-releasing Pt(iv)-prodrug.
Reshetnikov V; Arkhypov A; Julakanti PR; Mokhir A
Dalton Trans; 2018 May; 47(19):6679-6682. PubMed ID: 29708261
[TBL] [Abstract][Full Text] [Related]
31. Kinetics and mechanisms of activation of alpha-amino acid ester prodrugs of camptothecins.
Song L; Bevins R; Anderson BD
J Med Chem; 2006 Jul; 49(14):4344-55. PubMed ID: 16821794
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and one-electron reduction characteristics of radiation-activated prodrugs possessing two 5-fluorodeoxyuridine units.
Tanabe K; Sugiura M; Ito T; Nishimoto S
Bioorg Med Chem; 2012 Sep; 20(17):5164-8. PubMed ID: 22847019
[TBL] [Abstract][Full Text] [Related]
33. Nanoprodrug of retinoic acid-modified paclitaxel.
Zhou Z; Yan J; Sun T; Wang X; Xie Z
Org Biomol Chem; 2017 Nov; 15(45):9611-9615. PubMed ID: 29106434
[TBL] [Abstract][Full Text] [Related]
34. Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model.
Vignaroli G; Iovenitti G; Zamperini C; Coniglio F; Calandro P; Molinari A; Fallacara AL; Sartucci A; Calgani A; Colecchia D; Mancini A; Festuccia C; Dreassi E; Valoti M; Musumeci F; Chiariello M; Angelucci A; Botta M; Schenone S
J Med Chem; 2017 Jul; 60(14):6305-6320. PubMed ID: 28650650
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of new 4beta-anilino- and 4beta-imido-substituted podophyllotoxin congeners.
Kamal A; Gayatri NL; Reddy DR; Mohan Reddy PS; Arifuddin M; Dastidar SG; Kondapi AK; Rajkumar M
Bioorg Med Chem; 2005 Nov; 13(22):6218-25. PubMed ID: 16061385
[TBL] [Abstract][Full Text] [Related]
36. PMPA and PMEA prodrugs for the treatment of HIV infections and human papillomavirus (HPV) associated neoplasia and cancer.
Pertusati F; Hinsinger K; Flynn ÁS; Powell N; Tristram A; Balzarini J; McGuigan C
Eur J Med Chem; 2014 May; 78():259-68. PubMed ID: 24686012
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antitumor activities of water-soluble benzoylphenylureas.
Okada H; Kato M; Koyanagi T; Mizuno K
Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):430-3. PubMed ID: 10212393
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy.
Zhu W; Gao YH; Song CH; Lu ZB; Namulinda T; Han YP; Yan YJ; Wang LX; Chen ZL
Photochem Photobiol Sci; 2017 Nov; 16(11):1623-1630. PubMed ID: 28933502
[TBL] [Abstract][Full Text] [Related]
39. Sulfonyl-containing nucleoside phosphotriesters and phosphoramidates as novel anticancer prodrugs of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP).
Sun YW; Chen KM; Kwon CH
Mol Pharm; 2006; 3(2):161-73. PubMed ID: 16579645
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of taxoids 5. Synthesis and evaluation of novel water-soluble prodrugs of a 3'-desphenyl-3'-cyclopropyl analogue of docetaxel.
Yamaguchi T; Harada N; Ozaki K; Arakawa H; Oda K; Nakanishi N; Tsujihara K; Hashiyama T
Bioorg Med Chem Lett; 1999 Jun; 9(12):1639-44. PubMed ID: 10397492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]